R. Ian Lennox

R. IAN LENNOX is President and Chief Executive Officer of Drug Royalty
Corporation Inc. based in Toronto, Canada. Mr. Lennox was President and
CEO of Monsanto Canada Inc., between 1991-1996 where he managed a
diverse portfolio of businesses including pharmaceuticals, agricultural
and performance chemicals, food ingredients as well as an emerging
biotechnology presence. Under his leadership, Monsanto acquired several
new businesses, built a high growth Roundup franchise and increased
operating earnings fourfold. Prior to his return to Canada, he spent ten
years with Monsanto Company as Director, Latin American Operations,
Director, Western United States Region, and Business Manager,
Pharmaceuticals. In addition to his responsibilities at Drug Royalty,
Mr. Lennox is a member of the board of several publicly traded firms
including GenSci Inc., Hemosol Inc. and Marsulex Inc., and MDS Capital
Corp. Mr. Lennox has played an important role in industry-government
community associations in Canada. He was Chairman, International Centre
of Agriculture, Science and Technology based in Saskatoon (1992-94);
Chairman of the Canadian Chemical Advisory Council based in Ottawa
(1994-96); Chairman of the Canadian Chemical Producers’ Association
(1995-96); Chairman of the 1966 Peel United Way Campaign; Chairman of
The Mississauga Hospital Foundation (1994-96) and a member of the board
of the Mississauga Hospital and Junior Achievement of Canada (1991-95).
Mr. Lennox was a recipient of the Mississauga Citizenship Award (1996)
and the Rotary Club’s Paul Harris Fellowship Award (1977). Mr. Lennox is
an honours graduate in physiology and pharmacology. He has an MBA from
the Ivey School of Business, University of Western Ontario, and studied
advanced business management at Columbia Business School in New York. He
resides in Oakville, Ontario with his wife, Barbara, and their four
sons, Ryan, Craig, Derek and Blake.